Loss of Let-7 MicroRNA Upregulates IL-6 in Bone Marrow-Derived Mesenchymal Stem Cells Triggering a Reactive Stromal Response to Prostate Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of Let-7 MicroRNA Upregulates IL-6 in Bone Marrow-Derived Mesenchymal Stem Cells Triggering a Reactive Stromal Response to Prostate Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 8, Pages e71637
Publisher
Public Library of Science (PLoS)
Online
2013-08-20
DOI
10.1371/journal.pone.0071637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo Targeting of ADAM9 Gene Expression Using Lentivirus-Delivered shRNA Suppresses Prostate Cancer Growth by Regulating REG4 Dependent Cell Cycle Progression
- (2013) Che-Ming Liu et al. PLoS One
- The reactive stroma microenvironment and prostate cancer progression
- (2012) David A Barron et al. ENDOCRINE-RELATED CANCER
- Determining Prostate Cancer-Specific Death through Quantification of Stromogenic Carcinoma Area in Prostatectomy Specimens
- (2011) Gustavo E. Ayala et al. AMERICAN JOURNAL OF PATHOLOGY
- Lineage relationship of prostate cancer cell types based on gene expression
- (2011) Laura E Pascal et al. BMC Medical Genomics
- Human Prostate Cancer Harbors the Stem Cell Properties of Bone Marrow Mesenchymal Stem Cells
- (2011) H. E. Zhau et al. CLINICAL CANCER RESEARCH
- Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
- (2011) Kuo–Shu Tsai et al. GASTROENTEROLOGY
- IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway
- (2011) A. Yadav et al. MOLECULAR CANCER RESEARCH
- IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR
- (2011) A Rojas et al. ONCOGENE
- IL-6 Stabilizes Twist and Enhances Tumor Cell Motility in Head and Neck Cancer Cells through Activation of Casein Kinase 2
- (2011) Ying-Wen Su et al. PLoS One
- Microrna let-7: an emerging next-generation cancer therapeutic
- (2010) D. Barh et al. Current Oncology
- A novel targeting modality for renal cell carcinoma: human osteocalcin promoter-mediated gene therapy synergistically induced by vitamin C and vitamin D3
- (2010) Nicole A. Johnson et al. JOURNAL OF GENE MEDICINE
- Targeting L1 Cell Adhesion Molecule Using Lentivirus-Mediated Short Hairpin RNA Interference Reverses Aggressiveness of Oral Squamous Cell Carcinoma
- (2010) Shiao-Chen Hung et al. MOLECULAR PHARMACEUTICS
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
- (2009) Dimitrios Iliopoulos et al. CELL
- Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer
- (2009) O. Dakhova et al. CLINICAL CANCER RESEARCH
- Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2
- (2009) S. Feng et al. MOLECULAR CANCER THERAPEUTICS
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis
- (2008) S.-Y. Sung et al. CANCER RESEARCH
- Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
- (2008) P. J. Mishra et al. CANCER RESEARCH
- Bone marrow-derived cells and tumor growth: Contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells
- (2008) Berber D. Roorda et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor
- (2008) Kamilla Malinowska et al. ENDOCRINE-RELATED CANCER
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started